Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Prevalence and Predictors of Neurocognitive Impairment Among HIV-infected Patients

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Infectious Diseases Clinical Research Program
National Institute of Allergy and Infectious Diseases (NIAID)
University of California, San Diego
Information provided by (Responsible Party):
Brian Agan, Uniformed Services University of the Health Sciences
ClinicalTrials.gov Identifier:
NCT00893815
First received: May 4, 2009
Last updated: June 14, 2016
Last verified: June 2016